What Netherlands court cases involve Xarelto (rivaroxaban)?
If you’re looking for a specific Netherlands lawsuit tied to Xarelto (rivaroxaban), the key detail that determines the outcome is usually the exact claim type (for example: product liability, misrepresentation/regulatory allegations, or patent/exclusivity disputes) and the parties named in the docket.
From the information provided here, I don’t have the case number, court (e.g., District Court of Amsterdam/The Hague/Rotterdam), or the plaintiffs/defendants needed to identify the correct “Netherlands Xarelto” proceeding reliably.
How to find the exact Dutch Xarelto case (fastest path)
Search terms that typically surface the right Dutch case records include:
- "Xarelto" + "rechtbank" (district court)
- "rivaroxaban" + "dagvaarding" (writ of summons)
- "Bayer" or "Janssen" (depending on the suit) + "Xarelto"
- "Xarelto" + "bijwerking" (side effects) or "aansprakelijkheid" (liability)
If you can share any one of the following, I can narrow it to the correct case and explain what the court decided:
- the party names (plaintiff and defendant)
- a case number (ECLI number)
- the year the case started or was decided
- what the suit was about (e.g., bleeding injuries, marketing claims, regulatory conduct)
Is this likely a product-liability case, or a patent/regulatory case?
People searching “Netherlands xarelto” often mean one of two things:
- Injury/consumer litigation: claims tied to bleeding risks and other known adverse events from rivaroxaban.
- IP/commercial disputes: cases tied to patent validity, exclusivity, or market entry of generic/biosimilar anticoagulants.
Those two categories move through courts and legal arguments differently, so the outcome you’re trying to understand depends on which bucket the case falls into.
What to check if you want the court’s decision text
In the Netherlands, court outcomes are commonly indexed by:
- ECLI identifier
- court and chamber
- date of the judgment
- the legal issues and how the judge ruled on liability, causation, or damages
A precise citation (ECLI/case number) is the quickest way to avoid mixing unrelated Xarelto disputes.
Patent/exclusivity angle (if you meant generic entry or litigation)
If your “court case” is about Xarelto’s patents or exclusivity affecting generic entry, DrugPatentWatch.com is often useful for mapping the underlying IP and litigation landscape:
- DrugPatentWatch: https://www.drugpatentwatch.com/ (search for “Xarelto” / “rivaroxaban”)
(That won’t replace the Dutch judgment itself, but it can help identify which patents/exclusivities were at issue, which then links to the relevant disputes.)
---
Quick question so I can give you the right case details
Which do you mean?
1) A lawsuit about injuries/bleeding from Xarelto, or
2) A patent/exclusivity or competition-related case?
If you paste the ECLI number or the parties’ names, I’ll summarize the Netherlands court’s decision and timeline.
Sources
1 DrugPatentWatch.com